These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2108854)

  • 21. Comparative time course of thrombolysis induced by intravenous boluses and infusion of staphylokinase and tissue plasminogen activator in a rabbit arterial thrombosis model.
    Helft G; Bara L; Bloch MF; Samama MM
    Blood Coagul Fibrinolysis; 1998 Jul; 9(5):411-7. PubMed ID: 9712289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy.
    Vaughan DE; Goldhaber SZ; Kim J; Loscalzo J
    Circulation; 1987 Jun; 75(6):1200-3. PubMed ID: 3105914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The usefulness of systemic administration of recombinant human tissue-type plasminogen activator in femoral arterial thrombolysis of rabbits.
    Mino T; Suzuki J; Hayashi H
    Jpn J Pharmacol; 1989 Aug; 50(4):429-33. PubMed ID: 2476578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombolysis using consecutive high dose bolus and infusion of alteplase in a patient with acute massive pulmonary embolism.
    Tebbe U; Seifried E; Carlsson J; Tanswell P
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):475-80. PubMed ID: 1420824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombolytic treatment of acute pulmonary embolism.
    Charbonnier B; Meyer G; Stern M; Sors H; Brochier ML
    Herz; 1989 Jun; 14(3):157-71. PubMed ID: 2500388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.
    Wang C; Zhai Z; Yang Y; Wu Q; Cheng Z; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH;
    Chest; 2010 Feb; 137(2):254-62. PubMed ID: 19741062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombolytic therapy of deep venous thrombosis with rt-PA].
    Zimmermann R; Horn A; Harenberg J; Diehm C; Müller-Bühl U; Kübler W
    Klin Wochenschr; 1988; 66 Suppl 12():137-42. PubMed ID: 3126342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombolytic therapy in children--clinical experiences with recombinant tissue-plasminogen activator.
    Knöfler R; Dinger J; Kabus M; Müller D; Lauterbach I; Rupprecht E; Taut-Sack H; Weissbach G
    Semin Thromb Hemost; 2001; 27(2):169-74. PubMed ID: 11372772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series].
    Schermer E; Streif W; Genser N; Frühwirth M; Trawöger R; Simma B
    Wien Klin Wochenschr; 2000 Nov; 112(21):927-33. PubMed ID: 11144008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis.
    Marder VJ; Brenner B; Totterman S; Francis CW; Rubin R; Rao AK; Kessler CM; Kwaan HC; Sharma GV; Fong KL
    J Lab Clin Med; 1992 May; 119(5):485-95. PubMed ID: 1583404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion.
    Goldhaber SZ; Haire WD; Feldstein ML; Miller M; Toltzis R; Smith JL; Taveira da Silva AM; Come PC; Lee RT; Parker JA
    Lancet; 1993 Feb; 341(8844):507-11. PubMed ID: 8094768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in systemic fibrinolysis and blood coagulation parameters in local thrombolysis with tissue plasminogen activator (rt-PA)].
    Klein P; Roth FJ; Rieger H; Popov-Cenic S
    Vasa; 1992; 21(3):249-52. PubMed ID: 1529628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism.
    Islam MS
    Adv Exp Med Biol; 2017; 906():67-74. PubMed ID: 27628004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thrombolysis with rt-PA in children with arterial and venous thromboses--a new therapy concept].
    Nowak-Göttl U; Kreuz WD; Schwabe D; Linde R; Kornhuber B
    Klin Padiatr; 1991; 203(5):359-62. PubMed ID: 1942942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small animal thrombosis models for the evaluation of thrombolytic agents.
    Stassen JM; Lijnen HR; Kieckens L; Collen D
    Circulation; 1991 Jun; 83(6 Suppl):IV65-72. PubMed ID: 2040073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Local low dosage thrombolysis with rt-PA. Systemic effects on the fibrinolytic system--data on the assessment of the value and risk of this method].
    von Bilderling P; Spannagl M; Mietaschk A; Iven M; Schramm W; Hess H
    Vasa Suppl; 1991; 33():132-3. PubMed ID: 1788645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Daily catheter-directed single dosing of t-PA in treatment of acute deep venous thrombosis of the lower extremity.
    Chang R; Cannon RO; Chen CC; Doppman JL; Shawker TH; Mayo DJ; Wood B; Horne MK
    J Vasc Interv Radiol; 2001 Feb; 12(2):247-52. PubMed ID: 11265890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators.
    Chest; 1990 Mar; 97(3):528-33. PubMed ID: 2106408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin.
    Cercek B; Lew AS; Hod H; Yano J; Reddy NK; Ganz W
    Circulation; 1986 Sep; 74(3):583-7. PubMed ID: 3091287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanning.
    Parker JA; Markis JE; Palla A; Goldhaber SZ; Royal HD; Tumeh S; Kim D; Rustgi AK; Holman BL; Kolodny GM
    Radiology; 1988 Feb; 166(2):441-5. PubMed ID: 3122266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.